title: Effects of moderate physical training on prednisone-induced protein wasting: a study of whole-body and bone protein metabolism.
abstract: This study investigated the possibility of preventing prednisone-induced protein wasting by regular physical activity. Eight healthy untrained volunteers took prednisone (30 mg/d for nine days), once after a 4-week exercise program that consisted of jogging 2.5 miles four times a week, and once without exercise. Whole body protein turnover was measured from the 15N enrichment plateau of urinary ammonia during ingestion of 15N glycine at hourly intervals. Whole-body protein synthesis and breakdown were derived from nitrogen flux, nitrogen intake, and urinary nitrogen elimination. Muscle myofibrillar protein breakdown was explored by measuring urinary 3-methylhistidine excretion. Bone protein metabolism was studied by measuring serum bone GLA protein (BGP), a specific marker of bone protein synthesis, and urinary elimination of hydroxyproline, an index of bone resorption. Whole-body protein turnover was significantly increased by exercise and prednisone (+19% and +17%, respectively); this effect was related to increased protein synthesis during exercise training (+27%, P less than .01) and to increased protein breakdown during prednisone administration without exercise (+21%, P less than .05). In contrast, values of protein turnover, synthesis, and breakdown were not different from control when the subjects took prednisone after training. Urinary excretion of 3-methylhistidine was decreased (-15%, P less than .05) at the end of the prednisone administration period but was identical to the control value when the subjects took prednisone in association with exercise. In contrast, serum BGP was significantly decreased by prednisone, with or without exercise (-35%, P less than .001). These data suggest that moderate exercise training can prevent, at least in part, the protein loss induced by prednisone.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Clinique Endocrinologique, Hôpital de l'Antiquaille, Lyon, France.
authors.forename: D R
authors.initials: DR
authors.lastname: Garrel
authors.forename: P D
authors.initials: PD
authors.lastname: Delmas
authors.forename: C
authors.initials: C
authors.lastname: Welsh
authors.forename: M J
authors.initials: MJ
authors.lastname: Arnaud
authors.forename: S E
authors.initials: SE
authors.lastname: Hamilton
authors.forename: M M
authors.initials: MM
authors.lastname: Pugeat
mesh_terms: D000328:Adult; D001835:Body Weight; D001842:Bone and Bones / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000097:blood; D006801:Humans; D008297:Male; D008762:Methylhistidines / Q000652:urine; D015675:Osteocalcin; D010012:Osteogenesis; D010024:Osteoporosis / Q000139:chemically induced; D010806:Physical Education and Training; D011241:Prednisone / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism*
chemical_list: D002135:Calcium-Binding Proteins; D008762:Methylhistidines; D011506:Proteins; D015675:Osteocalcin; C028118:3-methylhistidine; D011241:Prednisone